Reported May 27, 2026 · Ongoing
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108,…
Lupin Pharmaceuticals Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Lupin Pharmaceuticals Inc. · 5801 Pelican Bay Blvd Ste 500 · Naples, FL · 34108-2734
Is this the product you have?
- Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only
- Manufactured forLupin Pharmaceuticals, Inc., Naples, FL 34108
- Manufactured by
Lupin LimitedNagpur 441108INDIAa) 2 Pens- NDC 70748-346-02b) 3 Pens - NDC 70748-346-03
- Lot codes and dates
- Lots
a) WB00097WB00094WB00088
- Expires
Jul. 2027WB00103
- Expires
Oct. 2027WC00016
- Expires
Dec. 2027b) WB00098WB00092WB00093
- Expires
Jul. 2027WB00104WB00106WB00105
- ExpiresOct. 2027
- Lots
- Amount recalled
- 217,621 pen injectors
Where it was sold
- Nationwide
Why it was recalled
Presence of particulate matter: a white thread-like structure in the cartridge
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Lupin Pharmaceuticals Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.